Racial Disparities in Access to Medication for Addiction Treatment

In this study, CA Bridge identifies racial disparities in accessing medication-assisted treatment (MAT), specifically looking at buprenorphine, in California.

Source: CA Bridge

Previous
Previous

Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada

Next
Next

Equity and Harm Reduction for Communities of Color